| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/29/2001 | DE19945787A1 Arylsulfonamid-substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Arylsulfonamide-substituted benzimidazole derivatives, processes for their preparation and their use as medicaments |
| 03/29/2001 | DE19945594A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments |
| 03/29/2001 | DE19939707A1 Use of new and known amine compounds for stimulating neuronal activity for treating e.g. Alzheimer's and Parkinson's disease, neuralgias and multiple sclerosis |
| 03/29/2001 | CA2385447A1 Pyrazole derivatives |
| 03/29/2001 | CA2384296A1 Therapeutic quinazoline derivatives |
| 03/29/2001 | CA2384291A1 Quinazoline derivatives and their use as pharmaceuticals |
| 03/29/2001 | CA2384284A1 Quinazoline derivatives |
| 03/29/2001 | CA2384282A1 Quinazoline compounds and pharmaceutical compositions containing them |
| 03/29/2001 | CA2383157A1 Insecticidal and acaricidal agents |
| 03/29/2001 | CA2383147A1 Mch antagonists |
| 03/28/2001 | EP1086992A1 Mono- and dipotassium salts of azocompounds |
| 03/28/2001 | EP1086950A1 Heterocyclic indole derivatives and mono- or diazaindole derivatives |
| 03/28/2001 | EP1086947A1 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| 03/28/2001 | EP1086946A1 Benzamidine derivative |
| 03/28/2001 | EP1086103A1 Pyrido 2,3-b]indolizine derivatives and aza analogues thereof; crf 1? specific ligands |
| 03/28/2001 | EP1086099A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 03/28/2001 | EP1086097A1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 03/28/2001 | EP1086095A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
| 03/28/2001 | EP1086094A1 Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity |
| 03/28/2001 | EP1086093A1 Tetrahydroquinoline derivatives as glycine antagonists |
| 03/28/2001 | EP1086088A2 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |
| 03/28/2001 | EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 03/28/2001 | EP1086084A1 Tetraisoquinololine derivatives as modulators of dopamine d3 receptors |
| 03/28/2001 | EP1086083A1 Protease inhibitors |
| 03/28/2001 | EP1086066A1 Muscarinic receptor antagonists |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086063A1 Novel potassium channel drugs and their uses |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085853A1 Heterocyclic ester and amide hair growth compositions and uses |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP1085845A2 Multibinding inhibitors of cyclooxygenase-2 |
| 03/28/2001 | EP0820446A4 Synthesis of bis-indolylmaleimides |
| 03/28/2001 | EP0775132B1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 03/28/2001 | CN1289336A Chemokine receptor antagonists and methods of use therefor |
| 03/28/2001 | CN1289331A Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 03/28/2001 | CN1289330A Substituted heteroarylmethyl compounds used as herbicides |
| 03/28/2001 | CN1289326A N-[(substituted five-membered di-or thiaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia |
| 03/28/2001 | CN1289324A Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
| 03/28/2001 | CN1289321A Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
| 03/28/2001 | CN1288893A Tacrine derivative for treatment of senlie dementia |
| 03/28/2001 | CN1288887A Monopotassium salt and dipotassium salt of azo-compound |
| 03/28/2001 | CN1063748C Naphthalene derivatives, process for preparation thereof and intermediates thereof |
| 03/28/2001 | CN1063747C Quinotone and naphthyridonecarboxylic acid derivatives |
| 03/27/2001 | US6207836 Indolin-2-one derivatives |
| 03/27/2001 | US6207829 Cyclization of a corresponding pyrazole compound |
| 03/27/2001 | US6207697 Amidinyl-substituted rings; anticoagulants; thromboembolic disorders; antiischemic and antiinflammatory agents; strokes; serine protease inhibitors |
| 03/27/2001 | US6207693 Benzamide derivatives having a vasopressin antagonistic activity |
| 03/27/2001 | US6207692 2-[1′,2′,4′-Triazol-3′-yloxymethylene] anilides, their preparation and their use |
| 03/27/2001 | US6207687 Substituted imidazoles having cytokine inhibitory activity |
| 03/27/2001 | US6207680 Heteroarylpiperidines and their use as antipsychotics and analgesics |
| 03/27/2001 | US6207679 Antimicrobial agents uses and compositions related thereto |
| 03/27/2001 | US6207677 Adminisering sigma receptor binding piperidine derivative for treating anxiety, epilepsy, convulsion, movement disorder, amnesia |
| 03/27/2001 | US6207676 Bicyclic amines |
| 03/27/2001 | US6207667 1,3 diazines with platelet-derived growth factor receptor inhibitory activity |
| 03/27/2001 | US6207665 To treat inflammatory disorders in humans |
| 03/27/2001 | US6207618 Heterocyclic substituted 4-benzoyl-pyrazole as herbicides |
| 03/27/2001 | US6207444 Contacting racemic compound with proteinase k, subtilisin, or a protease enzyme from metarhizium to form enantiomorph; chemical intermediate of drug which treats benign prostatic hyperplasia |
| 03/27/2001 | US6207188 Omeprazole sodium salt |
| 03/27/2001 | CA2091562C Indole derivatives useful in psychotherapeutics |
| 03/27/2001 | CA2033771C Indolylpropanols, process for their preparation and their use and preparations containing the compounds |
| 03/22/2001 | WO2001020078A1 Chlorohydrin and cationic compounds having high affinity for pulp or paper |
| 03/22/2001 | WO2001019939A1 Fluorescent maleimides and uses thereof |
| 03/22/2001 | WO2001019822A1 Antiviral agents |
| 03/22/2001 | WO2001019817A2 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| 03/22/2001 | WO2001019816A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 03/22/2001 | WO2001019815A1 Novel 2-(2-pyridyl)pyrimidine derivatives |
| 03/22/2001 | WO2001019802A1 Aromatic nitrogenous six-membered ring compounds |
| 03/22/2001 | WO2001019800A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 03/22/2001 | WO2001019798A2 INHIBITORS OF FACTOR Xa |
| 03/22/2001 | WO2001019797A2 HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 03/22/2001 | WO2001019795A1 Azacycloalkanone serine protease inhibitors |
| 03/22/2001 | WO2001019793A1 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same |
| 03/22/2001 | WO2001019791A2 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments |
| 03/22/2001 | WO2001019788A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 03/22/2001 | WO2001019322A2 Use of csaids in rhinovirus infection |
| 03/22/2001 | WO2000055155A3 Heterocyclic compounds as adenosine deaminase inhibitors |
| 03/22/2001 | WO2000001376A3 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | DE19945245A1 Mono- und Dikaliumsalze von Azoverbindungen Mono- and dipotassium salts of azo compounds |
| 03/22/2001 | DE19944332A1 Antikonvulsiv und anxiolytisch wirkende 4-Amino-1-aryl-1,5-dihydro-pyrrol-2-one und Verfahren zu deren Herstellung Anticonvulsant and anxiolytic 4-amino-1-aryl-1,5-dihydro-pyrrol-2-one and processes for their preparation |
| 03/22/2001 | CA2385722A1 Use of csaids in rhinovirus infection |
| 03/22/2001 | CA2385589A1 Inhibitors of factor xa |
| 03/22/2001 | CA2384898A1 Antiviral agents |
| 03/22/2001 | CA2384247A1 Azacycloalkanone serine protease inhibitors |
| 03/22/2001 | CA2382448A1 Chlorohydrin and cationic compounds having high affinity for pulp or paper |
| 03/22/2001 | CA2382149A1 Fluorescent maleimides and uses thereof |
| 03/22/2001 | CA2381252A1 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| 03/22/2001 | CA2377221A1 Hydroxyalkanoyl aminolactams and related structures as inhibitors of a.beta. protein production |
| 03/21/2001 | EP1085371A1 Photographic material containing a novel hydrazide type |
| 03/21/2001 | EP1085019A1 Omeprazole synthesis |
| 03/21/2001 | EP1085000A1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |